Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1804050 | 0.87 | HSD17B10 (0.41) | HSD17B10L3MBTL1GAASLC2A1CA1 | |
| SCHEMBL14991138 | 0.87 | HSD17B10 (0.44) | HSD17B10L3MBTL1GAASLC2A1CA1 | |
| SCHEMBL1808453 | 0.86 | CYP2D6 (0.47) | HSD17B10L3MBTL1ADRA1ATAAR1GAA | |
| SCHEMBL1808452 | 0.86 | HSD17B10 (0.41) | HSD17B10L3MBTL1ADRA1ATAAR1GAA | |
| SCHEMBL1805383 | 0.84 | TAAR1 (0.57) | ADRA1ATAAR1GAA | |
| SCHEMBL1607332 | 0.83 | HSD17B10 (0.44) | HSD17B10L3MBTL1GAASLC2A1CA1 | |
| SCHEMBL1803007 | 0.82 | HSD17B10 (0.42) | HSD17B10L3MBTL1GAAPTGS2SLC2A1 | |
| SCHEMBL1803005 | 0.82 | HSD17B10 (0.42) | HSD17B10L3MBTL1GAASLC2A1CA1 | |
| SCHEMBL1804056 | 0.81 | ADRA1A (0.44) | HSD17B10ADRA1ATAAR1GAASLC2A1 | |
| SCHEMBL16272791 | 0.81 | MEN1 (0.46) | PTGS2SLC2A1MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8404036-B2 | Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | IK, RB1, COL1A1 | HSD17B10 2848/4885L3MBTL1 2085/4885ADRA1A 2224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.